Wegovy will be the Variation of semaglutide which is intended far more for weight loss. Novo Nordisk claimed at the end of December that there was full availability of all doses of Wegovy for pharmacies nationwide. This was immediately after months of "unprecented" demand for Wegovy asRybelsus and copyright brought on thyroid tumors in mice and rat